SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-19-003229
Filing Date
2019-04-24
Accepted
2019-04-24 16:10:32
Documents
4
Period of Report
2019-06-20
Effectiveness Date
2019-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a.htm DEF 14A 942985
2 GRAPHIC def14ag001.jpg GRAPHIC 6518
3 GRAPHIC def14ag002.gif GRAPHIC 112370
4 GRAPHIC def14ag003.gif GRAPHIC 72745
  Complete submission text file 0001558370-19-003229.txt   1208170
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37719 | Film No.: 19763955
SIC: 2834 Pharmaceutical Preparations